HK Stock MarketDetailed Quotes

3D MEDICINES (01244)

Watchlist

5.830
+0.010+0.17%

Trading Jan 16 11:05 CST

1.51BMarket Cap-8.14P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

3D MEDICINES (01244) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Turnover

1.33%209.17M

-29.81%445.65M

-41.45%206.42M

11.91%634.95M

--352.55M

841.57%567.39M

--60.26M

----

Operating income

1.33%209.17M

-29.81%445.65M

-41.45%206.42M

11.91%634.95M

352.55M

841.57%567.39M

60.26M

Cost of sales

6.94%-16.26M

25.50%-36.57M

36.00%-17.47M

-16.29%-49.09M

---27.3M

-887.02%-42.22M

---4.28M

----

Operating expenses

6.94%-16.26M

25.50%-36.57M

36.00%-17.47M

-16.29%-49.09M

-27.3M

-887.02%-42.22M

-4.28M

Gross profit

2.09%192.91M

-30.18%409.08M

-41.91%188.95M

11.55%585.86M

325.25M

838.10%525.18M

55.98M

Selling expenses

-1.33%-111.55M

37.72%-235.94M

50.18%-110.08M

-5.91%-378.81M

---220.97M

-734.99%-357.66M

---42.83M

----

Administrative expenses

31.65%-29.74M

63.95%-78.26M

44.49%-43.5M

-51.98%-217.08M

---78.37M

5.38%-142.83M

-272.47%-150.96M

1.37%-40.53M

---41.09M

Research and development expenses

2.54%-83.12M

57.53%-180.72M

43.74%-85.29M

-21.27%-425.5M

---151.61M

5.47%-350.86M

-40.61%-371.16M

-15.07%-263.97M

---229.39M

Revaluation surplus

----

31.17%-657.16M

-199.07%-954.74M

-23,830.43%-319.23M

---1.33M

-Changes in the fair value of other assets

----

31.17%-657.16M

-199.07%-954.74M

-23,830.43%-319.23M

---1.33M

Impairment and provision

39.15%-2.9M

-1,301.55%-10.06M

-1,622.38%-4.77M

171.23%837K

---277K

-803.85%-1.18M

---130K

----

-Other impairment is provision

39.15%-2.9M

-1,301.55%-10.06M

-1,622.38%-4.77M

171.23%837K

---277K

-803.85%-1.18M

---130K

----

Special items of operating profit

-1.24%-54.99M

21.69%-93.98M

9.77%-54.32M

-86.31%-120.01M

---60.19M

-1,917.47%-64.41M

198.66%3.54M

89.25%-3.59M

---33.41M

Operating profit

18.00%-89.39M

65.77%-189.88M

41.44%-109.01M

47.12%-554.69M

-186.16M

28.17%-1.05B

-132.78%-1.46B

-105.53%-627.32M

-305.23M

Financing cost

34.76%-3.3M

-22.27%-9.5M

-25.23%-5.06M

-149.66%-7.77M

---4.04M

-103.73%-3.11M

81.04%-1.53M

47.01%-8.06M

---15.21M

Earning before tax

18.75%-92.69M

64.55%-199.38M

40.03%-114.07M

46.54%-562.47M

-190.2M

28.03%-1.05B

-130.07%-1.46B

-98.29%-635.38M

-320.43M

Tax

--55K

----

---55K

----

After-tax profit from continuing operations

18.79%-92.63M

64.56%-199.38M

40.03%-114.07M

46.53%-562.52M

-190.2M

28.03%-1.05B

-130.07%-1.46B

-98.29%-635.38M

-320.43M

Earning after tax

18.79%-92.63M

64.56%-199.38M

40.03%-114.07M

46.53%-562.52M

-190.2M

28.03%-1.05B

-130.07%-1.46B

-98.29%-635.38M

-320.43M

Minority profit

68.92%-3.28M

55.81%-16.72M

9.85%-10.57M

-36.65%-37.82M

---11.72M

0.19%-27.68M

---27.73M

----

Profit attributable to shareholders

13.68%-89.35M

65.19%-182.66M

42.01%-103.51M

48.78%-524.7M

-178.49M

28.57%-1.02B

-125.71%-1.43B

-98.29%-635.38M

-320.43M

Basic earnings per share

14.29%-0.36

67.39%-0.75

46.84%-0.42

89.79%-2.3

-0.79

38.67%-22.52

-163.60%-36.72

-34.20%-13.93

-10.38

Diluted earnings per share

14.29%-0.36

67.39%-0.75

46.84%-0.42

89.79%-2.3

-0.79

38.67%-22.52

-163.60%-36.72

-34.20%-13.93

-10.38

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Hyundai Ancheng Certified Public Accountants Co., Ltd.

Ernst & Young

Ernst & Young Accounting Firm

Ernst & Young

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Turnover	1.33%209.17M	-29.81%445.65M	-41.45%206.42M	11.91%634.95M	--352.55M	841.57%567.39M	--60.26M	----	----
Operating income	1.33%209.17M	-29.81%445.65M	-41.45%206.42M	11.91%634.95M	352.55M	841.57%567.39M	60.26M
Cost of sales	6.94%-16.26M	25.50%-36.57M	36.00%-17.47M	-16.29%-49.09M	---27.3M	-887.02%-42.22M	---4.28M	----	----
Operating expenses	6.94%-16.26M	25.50%-36.57M	36.00%-17.47M	-16.29%-49.09M	-27.3M	-887.02%-42.22M	-4.28M
Gross profit	2.09%192.91M	-30.18%409.08M	-41.91%188.95M	11.55%585.86M	325.25M	838.10%525.18M	55.98M
Selling expenses	-1.33%-111.55M	37.72%-235.94M	50.18%-110.08M	-5.91%-378.81M	---220.97M	-734.99%-357.66M	---42.83M	----	----
Administrative expenses	31.65%-29.74M	63.95%-78.26M	44.49%-43.5M	-51.98%-217.08M	---78.37M	5.38%-142.83M	-272.47%-150.96M	1.37%-40.53M	---41.09M
Research and development expenses	2.54%-83.12M	57.53%-180.72M	43.74%-85.29M	-21.27%-425.5M	---151.61M	5.47%-350.86M	-40.61%-371.16M	-15.07%-263.97M	---229.39M
Revaluation surplus	----	----	----	----	----	31.17%-657.16M	-199.07%-954.74M	-23,830.43%-319.23M	---1.33M
-Changes in the fair value of other assets	----	----	----	----	----	31.17%-657.16M	-199.07%-954.74M	-23,830.43%-319.23M	---1.33M
Impairment and provision	39.15%-2.9M	-1,301.55%-10.06M	-1,622.38%-4.77M	171.23%837K	---277K	-803.85%-1.18M	---130K	----	----
-Other impairment is provision	39.15%-2.9M	-1,301.55%-10.06M	-1,622.38%-4.77M	171.23%837K	---277K	-803.85%-1.18M	---130K	----	----
Special items of operating profit	-1.24%-54.99M	21.69%-93.98M	9.77%-54.32M	-86.31%-120.01M	---60.19M	-1,917.47%-64.41M	198.66%3.54M	89.25%-3.59M	---33.41M
Operating profit	18.00%-89.39M	65.77%-189.88M	41.44%-109.01M	47.12%-554.69M	-186.16M	28.17%-1.05B	-132.78%-1.46B	-105.53%-627.32M	-305.23M
Financing cost	34.76%-3.3M	-22.27%-9.5M	-25.23%-5.06M	-149.66%-7.77M	---4.04M	-103.73%-3.11M	81.04%-1.53M	47.01%-8.06M	---15.21M
Earning before tax	18.75%-92.69M	64.55%-199.38M	40.03%-114.07M	46.54%-562.47M	-190.2M	28.03%-1.05B	-130.07%-1.46B	-98.29%-635.38M	-320.43M
Tax	--55K	----	----	---55K	----	----	----	----	----
After-tax profit from continuing operations	18.79%-92.63M	64.56%-199.38M	40.03%-114.07M	46.53%-562.52M	-190.2M	28.03%-1.05B	-130.07%-1.46B	-98.29%-635.38M	-320.43M
Earning after tax	18.79%-92.63M	64.56%-199.38M	40.03%-114.07M	46.53%-562.52M	-190.2M	28.03%-1.05B	-130.07%-1.46B	-98.29%-635.38M	-320.43M
Minority profit	68.92%-3.28M	55.81%-16.72M	9.85%-10.57M	-36.65%-37.82M	---11.72M	0.19%-27.68M	---27.73M	----	----
Profit attributable to shareholders	13.68%-89.35M	65.19%-182.66M	42.01%-103.51M	48.78%-524.7M	-178.49M	28.57%-1.02B	-125.71%-1.43B	-98.29%-635.38M	-320.43M
Basic earnings per share	14.29%-0.36	67.39%-0.75	46.84%-0.42	89.79%-2.3	-0.79	38.67%-22.52	-163.60%-36.72	-34.20%-13.93	-10.38
Diluted earnings per share	14.29%-0.36	67.39%-0.75	46.84%-0.42	89.79%-2.3	-0.79	38.67%-22.52	-163.60%-36.72	-34.20%-13.93	-10.38
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion
Auditor	--	Hyundai Ancheng Certified Public Accountants Co., Ltd.	--	Ernst & Young	--	Ernst & Young Accounting Firm	Ernst & Young	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?